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A B S T R A C T
Purpose: The European Union-funded E-PILEPSY network aims to improve awareness of, and
accessibility to, epilepsy surgery across Europe. In this study we assessed current clinical practices
in epilepsy monitoring units (EMUs) in the participating centers.
Method: A 60-item web-based survey was distributed to 25 centers (27 EMUs) of the E-PILEPSY network
across 22 European countries. The questionnaire was designed to evaluate the characteristics of EMUs,
including organizational aspects, admission, and observation of patients, procedures performed, safety
issues, cost, and reimbursement.
Results: Complete responses were received from all (100%) EMUs surveyed. Continuous observation of
patients was performed in 22 (81%) EMUs during regular working hours, and in 17 EMUs (63%) outside of
regular working hours. Fifteen (56%) EMUs requested a signed informed consent before admission. All
EMUs performed tapering/withdrawal of antiepileptic drugs, 14 (52%) prior to admission to an EMU.
Speciﬁc protocols on antiepileptic drugs (AED) tapering were available in four (15%) EMUs. Standardized
Operating Procedures (SOP) for the treatment of seizure clusters and status epilepticus were available in
16 (59%). Safety measures implemented by EMUs were: alarm seizure buttons in 21 (78%), restricted
patient’s ambulation in 19 (70%), guard rails in 16 (59%), and specially designated bathrooms in 7 (26%).
Average costs for one inpatient day in EMU ranged between 100 and 2200 Euros.
Conclusion: This study shows a considerable diversity in the organization and practice patterns across
European epilepsy monitoring units. The collected data may contribute to the development and
implementation of evidence-based recommended practices in LTM services across Europe.
 2016 The Authors. Published by Elsevier Ltd. on behalf of British Epilepsy Association. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Several studies over the past two decades have conﬁrmed the
essential role of long-term video-EEG monitoring in the evaluation
of patients with epilepsy [1–5]. Clinical applications of LTM are
divided into three main categories: (1) differential diagnosis
between non-epileptic and epileptic seizures (2) classiﬁcation and
characterization of seizure types and epilepsy syndromes, and (3)
presurgical evaluation of patients with medically refractory
epilepsy [6].
It is often necessary to use methods that provoke seizures in
order to achieve the principle goal of a LTM investigation. These
methods may include tapering and/or withdrawal of antiepileptic
drugs (AEDs), hyperventilation, sleep deprivation, and photic
stimulation, alone or in combination. Although LTM is generally
considered to be a safe procedure the seizure induction methods
can pose a potential threat to patients’ safety, and may result in
serious adverse events. These can include seizure clusters and
status epilepticus (SE), postictal psychosis, falls and physical
injuries, complications associated with invasive electrodes and
infrequently death [7–12].
Highly qualiﬁed personnel and adequate infrastructure/equip-
ment may play a fundamental role in achieving safe and effective
care of patients [6]. Furthermore, implementation of evidence-
based practice and adherence to standardized protocols is the key
to optimizing clinical decision making that may eventually lead to
better patient outcome and care experience [8]. The American
Clinical Neurophysiology Society (ACNS), the National Association
of Epilepsy Centers (NAEC), and the International League Against
Epilepsy (ILAE) released the guidelines and recommendations for
LTM; however, these guidelines relate mainly to services provided,
qualiﬁcation of personnel, and technical and methodological
considerations of video-EEG recording, while safety requirements
for LTM are only sparsely addressed [6,13,14]. Furthermore, the
most recent version of the ‘‘guideline for essential services,
personnel, and facilities in specialized epilepsy centers’’ from NAEC
is dated January 2010, while ‘‘Guideline Twelve: guidelines for
long-term monitoring for epilepsy’’ provided by ACNS was last
updated in 2008.Recent studies conducted in the United States by the American
Epilepsy Society (AES) and in Europe by the European Epilepsy
Monitoring Units Association (EEMA) demonstrated variety in
practice patterns among different centers and emphasized the lack
of appropriate safety culture in EMUs [8,15].
In 2014, an EU-funded pilot network of reference centers E-
PILEPSY [http://www.e-pilepsy.eu] was established with the
primary aim to increase the number of European patients being
cured from refractory epilepsy, through the enhancement of
epilepsy surgery in Europe. Under this view, the main task of the
E-PILEPSY is to reduce existing major inequalities in all aspects
related to epilepsy surgery and to harmonize and optimize
presurgical diagnostic procedures across European countries.
In order to provide insights into the current variability in
practices across European monitoring units, we conducted the
survey among the reference centers of the network.
2. Methods
2.1. Sample and procedure
The survey was approved by the E-PILEPSY network board. It
was conducted electronically: the 25 participating centers across
22 European countries were provided access to a web-page where
the survey could be ﬁlled in electronically. A unique survey link has
been created for each participant to ensure a single answer from a
single respondent. Data were collected between August 2014 and
January 2015. The investigator was available for questions and sent
reminders.
2.2. Survey instrument
The questionnaire consisted of 60 items; all questions
contained multiple choice components and covered the areas as
follows: EMU characteristics (8 questions), personnel, qualiﬁca-
tions, and responsibilities [5], admission to EMU [3], technical
equipment [3], procedures undertaken in EMU [11], tapering/
withdrawal of AEDs [15], safety issues and prevention of adverse
events [11], and reimbursement [4] (see supplementary material).
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Complete responses were received from all 25 reference centers
surveyed. Of these 25 centers, 23 included one EMU. Two reference
centers each had two separate EMUs, one dedicated to pediatric
patients and one to adult patients. Therefore, there were 27 EMUs
included in the present study. The results for the survey are
summarized in Tables 1–6.
3.1. General characteristics
Of the 27 (100%) EMUs, 17 (63%) evaluated both pediatric and
adult patients, 6 (22%) only adults and 4 (15%) only pediatric
patients. Twenty-seven (100%) EMUs admitted patients for
presurgical evaluation of epilepsy, 26 (96%) for differential
diagnosis, and 25 (93%) for classiﬁcation of seizure types and
epilepsy syndromes. Admission for seizure quantiﬁcation and
treatment modiﬁcation were reported by 16 (59%) and 10 (37%)
EMUs, respectively.
EMUs had between 1 and 11 beds, with the following
distribution: 1–2 beds in 10 (37%) EMUs, 3–5 beds in 15 (56%),
and 10–11 beds in 2 (7%). The large majority, i.e., 21 (78%) EMUs,
conducted both invasive and non-invasive video-EEG investigations,
while the remaining 6 (22%) only performed non-invasive inves-
tigations. The minimum number of hospital days for invasive
recordings ranged between 2 and 7 days and the maximum number
between 5 and 21 days. EMU characteristics are presented in Table 1.
3.2. Personnel, qualiﬁcations, and responsibilities
Professional qualiﬁcations of the staff involved in EMUs were
variable, including senior and resident neurologists for pediatricTable 1
Epilepsy Monitoring Unit (EMU) characteristics.
Mean duration of activity of the EMUs
The total number of patients admitted per yeara
The total number of admissions per year
Age distribution of patients
Adult patients (aged 18 years and above) 
Only adult patients 
Pediatric patients (aged 0–18 years) 
Neonates (aged 0–28 days) 
Infants (aged 28 days to 1 year) 
Children and adolescents (aged 1–18 years) 
Only pediatric patients 
Both 
Average duration of non-invasive monitoring
24 h or less 
1–3 days 
3–7 days 
1 week 
Average duration of invasive monitoring
Invasive monitoring not performed 
24 h or less 
1–3 days 
3–7 days 
1–2 weeks 
2 week 
Access to intensive therapy units
Intermediate care unit alone 
Intensive care unit alone 
Both 
None 
EMU: epilepsy monitoring unit.
a Data is provided for the period of 2013–2014, including all-and adult patients, neurophysiologists, biomedical engineers, EEG
technicians, and nurses. Data are shown in Table 2.
Continuous observation of patients was performed in 22 (81%)
EMUs during regular working hours and in 17 EMUs (63%) outside
of regular working hours. Observation was mainly conducted by
EEG technicians and nurses. During regular working hours
neurologists were involved in continuous observation in 3 EMUs
and in intermittent observation in 9 EMUs. Eight (30%) EMUs asked
patient’s relatives to observe patients’ behavior. In 1 (pediatric
EMU) out of 22 EMUs continuous observation of pediatric patients
was conducted by their parents, while EMU staff was only involved
in intermittent observation of the patients. Table 3 summarizes the
details on the modality of patient’s observation in EMU.
3.3. Admission to the EMU
Respondents were asked whether they use a questionnaire/
standardized form on patients’ admission to an EMU. The majority
of EMUs, i.e., 19 (70%) performed an interview on admission
through standardized questionnaires including issues on epilepsy
characteristics, history of previous injuries or SE, and comorbid-
ities. Two EMUs reported that similar information was obtained
from the patient’s history collected by an epileptologist (neurolo-
gist or neuropediatrician).
Fifteen (56%) of the 27 EMUs requested signed informed
consent from patients or their caregivers before admission. In the
twelve (44%) remaining EMUs physicians provided either infor-
mation leaﬂet alone (one EMU), or verbal instructions alone
(6 EMU), or verbal instructions were supported by information
leaﬂets (4 EMUs); one EMU obtained informed consent only for the
use of patients’ video-recordings for educational purposes. Results
are presented in Table 4.19 years (range 1–45 years)
5290
5877
No. (%) of EMUs;(n = 27)
Yes No
23 (85) 4 (15)
6 (22) 21 (78)
21 (78) 6 (22)
5 (19) 22 (81)
14 (52) 13 (48)
21 (78) 6 (22)
4 (15) 23 (85)
17 (63) 10 (37)
1 (4) 26 (96)
4 (15) 23 (85)
17 (63) 10 (37)
5 (19) 22 (81)
6 (22) 21(78)
0 (0) 27 (100)
0 (0) 27 (100)
9 (33) 18 (67)
10 (37) 17 (63)
2 (7) 25 (93)
7 (26) 20 (74)
2 (7) 25 (93)
16 (59) 11 (41)
2 (7) 25 (93)
cause EMU admissions, n = 27.
Table 3
Modality of patients’ observation in epilepsy monitoring unit.
Regular working hours Outside regular working hours
Continuousa Intermittentb Continuousa Intermittentb
No. (%) of EMUs
(n = 27)
No. (%) of EMUs
(n = 27)
No. (%) of EMUs
(n = 27)
No. (%) of EMUs
(n = 27)
22 (81) 5 (19) 17 (63) 10 (37)
EMU personnel involved in patients’ observationc
Neurologists
Fully trained neurologist(s) 3 (11) 5 (19) 1 (4) 2 (7)
Neurologist(s) in training 2 (7) 3 (11) 1 (4) 3 (11)
Fully trained pediatric neurologist(s) 2 (7) 2 (7) 1 (4) 0 (0)
Pediatric neurologist(s) in training 1 (4) 3 (11) 1 (4) 1 (4)
Neurophysiologist(s) 1 (4) 5 (19) 0 (0) 1 (4)
Biomedical engineer(s) 0 (0) 2 (7) 0 (0) 0 (0)
EEG technician(s) 15 (56) 5 (19) 4 (15) 2 (7)
Nurse(s) 13 (48) 4 (15) 10 (37) 5 (19)
Medical students trained for monitoring purposes 0 (0) 0 (0) 3 (11) 0 (0)
Non-medical students trained for monitoring purposes 0 (0) 0 (0) 1 (4) 0 (0)
Patients’ relatives 7 (26) 1 (4) 6 (22) 2 (7)
EMU: epilepsy monitoring unit.
The patients’ observation in EMU were performed by EMU personnel. However, in some EMUs patients’ relatives were also involved. In order to discriminate between
personnel and non-personnel the corresponding subheadings are highlighted in bold type.
a Indicates EMUs where patients are observed continuously by EMU personnel and/or patients’ relatives.
b Indicates EMUs where continuous observation of patients is not performed.
c Includes direct observation of the video/EEG/patient.
Table 2
Epilepsy monitoring unit personnel.
EMU staff No. (%) ofEMUs (n = 27) No. (%) of EMUs (n = 27) Min–Max number of personnel
Fully trained neurologist(s)a Yes No 0–7
22 (81) 5 (19)
Neurologist(s) in trainingb 21 (78) 6 (22) 0–4
Fully trained pediatric neurologist(s)a 17 (63) 10 (37) 0–3
Pediatric neurologist(s) in trainingb 10 (37) 17 (63) 0–5
Neurophysiologist(s) 12 (44) 15 (56) 0–6
Biomedical engineer(s) 10 (37) 17 (63) 0–3
EEG technician(s) 24 (89) 3 (11) 0–21
Nurse(s) 21 (78) 6 (22) 0–22
additionally trained as technicians 1 (4) 26 (96) n/a
PhD student(s) 1 (4) 26 (96) n/a
Medical students trained for monitoring purposes 4 (15) 23 (85) 0–25
Non-medical students trained in epileptology 2 (7) 25 (93) 0–1
Non-medical students trained for monitoring purposes 1 (4) 26 (96) n/a
Medical students not trained 2 (7) 25 (93) 0–3
Psychiatrist on call 21 (78) 6 (22) n/a
Neurosurgeon on call 22 (81) 5 (19) n/a
Anesthesiologist on call 21 (78) 6 (22) n/a
Non-physicians involved in preliminary screening of VEEG data
Biomedical engineers 1 (4) 26 (96) n/a
EEG technicians 12 (44) 15 (56) n/a
Nurses 4 (15) 23 (85) n/a
Students 1 (4) 26 (96) n/a
EMU: epilepsy monitoring unit, n/a: not applicable, VEEG: video-EEG monitoring.
a Consultant/attending physician/senior physician, etc.
b Registrar, resident, etc.
T. Kobulashvili et al. / Seizure 38 (2016) 38–45 413.4. Technical equipment
Respondents were asked which EEG system they use for long-
term video-EEG recordings.
Four different EEG systems were employed, by 11 (41%), 11
(41%), 6 (22%), and 2 (7%) EMUs, respectively. Furthermore, two
centers (7%) reported that they use in-house developed software.
The proportion of EMUs using various different types of
electrodes for invasive EEG recordings was the following: of 21
EMUs performing invasive video-EEG monitoring 19 (90%) EMUs
used depth electrodes; strip and grid electrodes were employed by
16 (76%) and 14 (67%) EMUs, respectively; combination of depth
and grid electrodes were shown in 14 (67%); less commonly used
electrode types were sphenoidal and foramen ovale electrodes,reported by 5 (24%) and 3 (14%) EMUs, respectively. Of these 21
EMUs, only 2 applied all types of invasive electrodes and another 2
were using depths electrodes exclusively.
Automatic seizure and spike detection software was imple-
mented in 5 (19%) out of 27 EMUs.
3.5. Procedures
Seventeen (63%) EMUs performed ictal single photon emission
computed tomography (SPECT) as part of the presurgical work-up.
The remaining centers reported lack of access to this resource. Of 17
centers performing SPECT 15 (88%) used manual injection of tracer,
performed by a physician or an EEG-technician. The remaining two
(12%) EMUs used a remotely operated injector pump.
Table 6
Cost and reimbursement methods for long-term video-EEG monitoring service.
No. (%) of EMUs; (n = 27)
Average cost for inpatient day
100–500 Euros 7 (26)
500–1000 6 (22)
1000–2200 8 (30)
No data available 6 (22)
Coverage/Reimbursement
By National Health System/National Health Service
Covered 12 (44)
Fully
Partly 5 (19)
Not covered 6 (22)
Othera 1 (4)
Reimbursed
Fully 0 (0)
Partly 4 (15)
Not reimbursed 20 (74)
By private insurance company/companies
Reimbursed
Fully 3 (11)
Partly 7 (26)
Not reimbursed 14 (52)
None 2 (7)
No data available 1 (4)
Procedures covered/reimbursed
By National Health System/National Health Service
Non-invasive VEEG 21 (78)
Invasive VEEG 17 (63)
Ictal SPECT 14 (52)
Cortical stimulation 13 (48)
By private insurance companies
Non-invasive VEEG 11 (41)
Table 4
Admission to epilepsy monitoring unit.
No. (%) of
EMUs (n = 27)
No. (%) of
EMUs (n = 27)
Yes No
Questionnaire/standardized form
used on admission
19 (70) 8 (30)
Neurological examination 25 (93) 2 (7)
Psychiatric examination 16 (59) 11(41)
By non-psychiatrist 13 (48) 14 (52)
By psychiatrist 4 (15) 23 (85)
By both 1 (4) 26 (96)
12-lead ECG 13 (48) 14 (52)
None 2 (7) 25 (93)
A written informed consenta 15 (56) 12 (44)
Written consent alone 9 (33) 18 (67)
An information leaﬂet/formb 9 (33) 18 (67)
Leaﬂet alone 1 (4) 26 (96)
Verbal information and
instruction
15 (56) 12 (44)
Verbal information and
instructions alone
6 (22) 21 (78)
None 1 (4) 26 (96)
EMU: epilepsy monitoring unit. ECG: electrocardiography.
a With signature of a patient and an informing physician.
b Without signature of a patient and an informing physician.
T. Kobulashvili et al. / Seizure 38 (2016) 38–45423.6. Safety issues and prevention of seizure-related adverse events
All EMUs reported that they use different seizure provocative
methods in order to increase the diagnostic yield of video-EEG
monitoring. More than half (56%) of EMUs reduced or completelyTable 5
Seizure provocative methods used in EMU.
No. (%) of
EMUs (n = 27)
No. (%) of
EMUs (n = 27)
Yes No
Tapering/withdrawal of AEDs 27(100) 0(0)
Up to 25% of cases 3 (11) 24 (89)
More than 25–50% of cases 5 (19) 22 (81)
More than 50–75% of cases 4 (15) 23 (85)
More than 75% to <100% 15 (56) 12 (44)
In all patients 0 (0) 27 (100)
Tapering/withdrawal of AEDs
prior to admission to an EMU
14 (52) 13 (48)
Up to 25% of cases 8 (30) 19 (70)
More than 25–50% of cases 2 (7) 25 (93)
More than 50–75% of cases 3 (11) 24 (89)
More than 75% to <100% 1(4) 26 (96)
In all patients 0 (0) 27 (100)
Setting
At home in all patients 3 (11) 24 (89)
In hospital in all patients 6 (22) 21 (78)
Decision based on individual case 5 (19) 22 (81)
Hyperventilation 25 (93) 2 (7)
Photic stimulation 21 (78) 6 (22)
Sleep deprivation 24 (89) 3 (11)
Physical exercise 4 (15) 23 (85)
Seizure triggering factors 3 (11) 24 (89)
For differential diagnosis of non-epileptic seizures
Verbal suggestion 19 (70) 8 (30)
Administration of placeboa 8 (30) 19 (70)
Other methodsb 7 (26) 20 (74)
EMU: epilepsy monitoring unit.
a Aministration of intravenous saline test, etc.
b Other methods include: administration of cold water to the skin of neck area
superﬁcially (1 EMU); any provocative method reported by the patient (1 EMU);
hyperventilation and sleep deprivation (4 EMUs); placebo, not administered
intravenously.
Invasive VEEG 11 (41)
Ictal SPECT 9 (33)
Cortical stimulation 5 (19)
EMU: epilepsy monitoring unit, VEEG: video-EEG monitoring.
a National health system only refers to those patients that are considered difﬁcult
to treat, insurance only pays 30% of the bill (1 EMU); covered by insurance
companies as a part of the total hospital budget, no direct payment/reimbursement
(2 EMUs).discontinued one or more antiepileptic drugs (AEDs) in 75–100% of
patients. Most common factors inﬂuencing the strategy of AEDs
tapering/withdrawal were seizure frequency, history of SE and
seizure clusters, seizures’ type and severity, and presurgical
evaluation. Fourteen (52%) of 27 EMUs performed tapering/
withdrawal of AEDs before admission. Three of these EMUs
prescribed tapering/withdrawal of AEDs at home, 6 in hospital
setting and in 5, individually based decisions were made. Speciﬁc
protocols of AEDs tapering/withdrawal were only available in 4
(15%) EMUs. Seventeen EMUs (63%) reported that they performed
therapeutic drug monitoring within EMU settings: one (4%)
performed it daily, 6 (22%) more than once during hospital stay,
5 (19%) only once, 2 (7%) rarely, 3 (11%) on an individual bases and
10 (37%) never. Data are summarized in Table 5.
Oxygen saturation was monitored in 12 (44%) EMUs, and peri-
ictal respiratory rate in 7 (26%). In contrast, monitoring of heart
rate was performed in almost all EMUs (n = 26, 96%). Standardized
Operating Procedures for the treatment of seizure clusters and SE
were available in 16 (59%) EMUs, while emergency resuscitation
equipment was in place in only 11 (41%). Prevention of venous
thrombosis was performed by 7 (26%) EMUs. Three of them
prescribed compression stockings, while subcutaneous low
molecular weight heparin was administered by all seven.
In order to prevent seizure-related adverse events, the
following safety measures were implemented: seizure alarm
buttons were available in 21 (78%) EMUs, 19 (70%) had restricted
patients’ ambulation and 9 (33%) allowed only accompanied
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were used in 16 (59%) EMUs. Specially designated bathrooms were
only available in 7 (26%), out-swing design for doors in 6 (22%),
padded toilet seats in 3 (11%), and shower seats in 6 (22%). Higher
nurse-to-patient ratio in EMUs compared to hospital ward was
reported by greater than half, i.e., 15 (56%) EMUs.
Participants were asked whether they systematically assessed
adverse events occurring in the EMU. Six (22%) EMUs reported that
they collected data retrospectively, 4 (15%) did this prospectively,
and in another 4 (15%), data were collected according to both
methods. In remaining 13 (48%) EMUs adverse events were not
systematically assessed and recorded. The data on various types of
adverse events occurring in EMUs were provided only by 8
respondents, other EMUs did not give answer to this question. The
following adverse events were observed: injuries, post-ictal
psychosis, mood disorders, generalized convulsion, bleeding, and
infection due to invasive recordings.
3.7. Cost and reimbursement
Twenty-one (78%) EMUs provided information on costs
associated with LTM service and the principles of repayment
within their healthcare reimbursement system. Six EMUs (repre-
senting 4 countries) were unable to report exact costs associated
with the procedure. However, two of these EMUs (representing a
single country) reported that the costs for hospital stays are
covered by insurance companies as part of the total hospital
budget, and there is no direct payment and/or reimbursement.
Another two EMUs (representing a single country) reported that
the healthcare system is completely public in their country.
The average cost for inpatient day ranged between 100 and 500
Euros in 26%, 500 and 1000 Euros in 22%, 1000 and 2200 Euros in
30%. The majority of EMUs (63%) reported that the costs associated
with LTM, including additional procedures required for invasive
recordings were covered by national health system. Reimburse-
ment by private insurances companies were reported by 41% of
respondents. Details are presented in Table 6.
4. Discussion
The ﬁndings from our survey revealed great heterogeneity in
current practice among European EMUs. Some practices discussed
below may pose a substantial risk to patients’ safety and therefore
demand reconsideration.
The level of observation throughout 24-h monitoring period
varied considerably between EMUs. Of 27 EMUs, including 6
performing only non-invasive monitoring and 21 both, invasive
and non-invasive monitoring, 10 (37%) were unable to provide
continuous 24-h observation. Off those 21 EMUs which were
performing invasive monitoring in 5 (24%) patients’ observation
was only intermittent. Furthermore, 67% of these EMUs used
subdural grids and 90% depths electrodes. Our ﬁndings differ from
those reported in two previous surveys conducted by AES and
EEMA, with 26% of EMUs in the United States and 20% in Europe not
having continuous observation. This can be explained in part by
different representation of centers/countries in these studies, as
well as possible differences in the deﬁnitions used for ‘‘continuous
observation’’.
The reduced level of observation, especially during invasive
presurgical evaluation may impose a substantial risk of severe
adverse events to the patients. In a survey conducted by American
Epilepsy Society (AES), 22 of 58 respondents (37.9%) reported that
patients pulled out or dislodged intracranial electrodes [9]. Recent
studies also reported signiﬁcant morbidity, such as subdural
hemorrhage and brain edema associated with intracranial EEG
monitoring and found the highest risk of complications whensubdural grid electrodes were used [10,11]. Wong et al., reported
that 2 (2.8%) of the 72 patients undergoing invasive monitoring
with grid electrodes died [16]. One of these patients was found
unresponsive, with no clinical seizures witnessed. However, EEG
revealed a seizure 2 h prior to death [16]. These studies highlight
the importance of adequate supervision provided by dedicated
staff especially in patients with implanted intracranial electrodes.
Signiﬁcant diversity was also shown in terms of qualiﬁcation
and number of personnel involved in patients monitoring. While
observation was mainly conducted by EEG technicians and nurses,
some centers also employed students outside of regular working
hours for monitoring purposes. Furthermore, qualiﬁcation of
personnel involved in observation throughout the day consider-
ably varied across each EMU. This issue has been addressed in a
study by Kandler et al., where authors recommended 24 h
surveillance by healthcare professionals with similar stafﬁng
throughout the monitoring period. Moreover, optimum nurse-to-
patient ratio not less than 1:4 was suggested as appropriate [17].
Within our survey the higher nurse-to-patient ratio compared to
hospital ward was observed in more than half EMUs.
Seizures in EMU can lead to cardio-respiratory arrest and death
[12]. Bateman et al. showed that oxygen desaturation below 90%
was observed in about one-third of seizures, and below 80% in
about 10% [18]. Although these studies clearly show the
importance of monitoring vital signs in EMU, our survey revealed
that continuous observation of oxygen saturation and respiratory
rate was performed in less than 40% of monitoring units and only in
case of life-threatening conditions, such as seizure clusters and SE.
Furthermore, availability of life supporting (resuscitative) equip-
ment and access to intensive care units was missing in 41% of
EMUs.
A recent study among the participating centers of the E-
PILEPSY consortium by Mouthaan et al. showed that ictal SPECT
is used by majority of centers both in adult and pediatric
patients. Main indications reported for performing SPECT were
negative MRI and/or discordant results on presurgical evaluation
[19]. However, some centers do not employ SPECT. Our study
showed the main reason for not performing SPECT was
unavailability of radionuclide tracer in ﬁve EMUs, and lack of
a SPECT gamma camera in three. Furthermore, two centers did
not consider SPECT a helpful diagnostic tool for delineating the
seizure onset zone.
Although more than half of EMUs perform tapering/withdrawal
of AEDs in 75–100% of patients, speciﬁc protocols were available
only in four. Our results are consistent with previous studies
[7,20,21] in which centers do not use standardized protocols and
taper/withdraw medication on experience based decisions.
Despite the high level of risk associated with medication
withdrawal in a non-hospital setting, our survey shows that three
of the EMUs instruct patients to withdraw medication at home in
all patients in order to have a higher diagnostic yield in a shorter
duration in the EMU.
Although SE is considered one of the most frequent adverse
events in EMU, SOPs required for the management of this condition
was available in only 14 (52%) EMUs.
Patients with psychiatric comorbidities have a 16-fold in-
creased risk of developing adverse events [7]. Psychiatric
complications in patients with pre-existing comorbidities may
require admission to psychiatric department or the management
of the condition within EMU setting.
Only two (7%) EMUs had developed a speciﬁc protocol for the
management of post-ictal psychosis and suicidality, while SOPs for
the management of panic attacks were only available in one (4%)
EMU.
Although LTM is considered a time consuming and relatively
expensive investigation, there are few, if any, studies evaluating its
T. Kobulashvili et al. / Seizure 38 (2016) 38–4544cost-effectiveness. Results of our survey showed a huge difference
in costs related to LTM in EMUs across Europe. This may be, in part,
attributed to heterogeneity of healthcare system and differences in
resource utilization and costs across different countries. The
reasons behind this disparity need further exploration.
Taking into account the considerable resources needed for
inpatient video-EEG monitoring, the beneﬁts of innovative
approaches such as home video-telemetry in a selected group of
patients can be signiﬁcant. Studies show that the home-telemetry
can be both safe and feasible [22,23]. Furthermore, chances of
successfully recorded seizure attacks may be increased while
patients are evaluated in their home environment, avoiding a huge
stress factor associated with hospital stay [24]. However, home-
telemetry has several limitations and the implementation of this
technique remains a challenge. Further research is needed to fully
explore the pros and cons of this innovative approach.
5. Conclusion
Our survey demonstrated considerable diversity in current
organization and practice across European epilepsy monitoring
units. We aimed to gain a deeper insight into variability of practice
among EMUs and identify the areas where harmonization and
improvement is needed. Moreover, the survey covers some issues
that have not been previously addressed in other studies and thus
complements the previous research in this domain which was
more focused on safety issues. Further, our research will be
supported by systematic reviews being undertaken within the E-
PILEPSY consortium.
Several important aspects that will later help to deﬁne
guidelines and can be potentially addressed by E-PILEPSY were
identiﬁed. Continuous monitoring by highly qualiﬁed staff
throughout a 24-h period is crucial to perform EMU activities
safely and effectively. When conducting invasive monitoring with
intracranial electrodes, this issue gains even more importance.
However, this is not always achieved due to ﬁnancial restrictions
that some centers experience. This further raises the issue of cost-
effective utilization of LTM. Obtaining signed informed consent on
admission, along with providing all relevant information including
possibility of SUDEP and SE has to be addressed. To manage life
threatening adverse events in a timely and effective manner,
availability of a well trained staff, continuous monitoring of vital
signs, and a proximity to intensive care unit are deemed necessary.
Furthermore, standardized protocols for management of SE,
seizure clusters, and postictal psychosis that could signiﬁcantly
improve patients’ outcome should be in place.
Adequate EMU infrastructure in terms of preventing seizure
related adverse events is pivotal. Future research is necessary to
identify factors that can both enable and hinder improvement of
safety.
We believe that the collected data will provide valuable insight
into the aforementioned issues. In conjunction with the systematic
literature reviews conducted by the consortium and the opinion of
expert panels, our study will contribute to the development and
implementation of evidence-based practice in EMUs across Europe.
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